Study of Daratumumab for Decreasing Circulating Antibodies in Sensitized Patients Awaiting Heart Transplantation
Clinical trial NCT04088903 · WITHDRAWN
Trial details
- NCT number
- NCT04088903
- Sponsor
- Ronald Witteles
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2023-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.